Paperpal Prime Logo

Toxicology and Applied Pharmacology : Impact Factor & More

eISSN: 1096-0333pISSN: 0041-008X

Aims and Scope of Toxicology and Applied Pharmacology

Toxicology and Applied Pharmacology is a scientific journal for original research pertaining to action of chemicals, drugs, or natural products to animals or humans. The journal covers mechanistic approaches to physiological, biochemical, cellular, or molecular understanding of toxicologic/pathologic lesions and to methods used to describe these responses. Less

Key Metrics

CiteScore
7.1
Impact Factor
< 5
SJR
Q1Toxicology
SNIP
0.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Toxicology and Applied Pharmacology

Toxicology and Applied Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ACADEMIC PRESS INC ELSEVIER SCIENCE
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1959
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Toxicology and Applied Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Toxicology and Applied Pharmacology

MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling
  • 1 Dec 2026
  • Toxicology and Applied Pharmacology
Preoperative serum miR-431-5p as a predictive biomarker for perioperative respiratory adverse events in children undergoing general anesthesia.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Shikonin suppresses fibrotic phenotype and oxidative stress in keloid fibroblasts via EGFR-targeted AKT/STAT3/PTGS2 modulation.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Myocardial senescence as a mechanistic endpoint of arsenic cardiotoxicity: Cysteine-associated p53/p21 activation and reversal by quercetin.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
The impacts of polystyrene nanoplastics on colorectal cancer: Evidence from integrated network toxicity and in vitro approaches.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
MRP4 deficiency exacerbates diet-induced MASLD through dysregulation of hepatic lipid handling
  • 1 Dec 2026
  • Toxicology and Applied Pharmacology
Preoperative serum miR-431-5p as a predictive biomarker for perioperative respiratory adverse events in children undergoing general anesthesia.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Shikonin suppresses fibrotic phenotype and oxidative stress in keloid fibroblasts via EGFR-targeted AKT/STAT3/PTGS2 modulation.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Levonorgestrel-ethinyl estradiol impairs hepatic lipid clearance to induce hypercholesterolemia via PCSK9-mediated LDLR and CD36 dysregulation.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
Myocardial senescence as a mechanistic endpoint of arsenic cardiotoxicity: Cysteine-associated p53/p21 activation and reversal by quercetin.
  • 1 Dec 2026
  • Toxicology and applied pharmacology
The impacts of polystyrene nanoplastics on colorectal cancer: Evidence from integrated network toxicity and in vitro approaches.
  • 1 Dec 2026
  • Toxicology and applied pharmacology

FAQs on Toxicology and Applied Pharmacology